Trump says may or may not approve stricter FDA guidelines for COVID-19 vaccine


WASHINGTON, Sept 23 (Reuters) - U.S. President Donald Trump said on Wednesday he may or may not approve potentially new, more stringent standards for an emergency authorization of a COVID-19 vaccine by the U.S. Food and Drug Administration, saying such a move would appear political.

The Washington Post reported on Tuesday the FDA would issue the guidance to boost transparency and public trust as health experts have become increasingly concerned the Trump administration might be interfering in the approval process.

"That has to be approved by the White House. We may or may not approve it," Trump told a White House news conference.

"That sounds like a political move."

(Reporting by Jeff Mason and Eric Beech, writing by Phil Stewart, editing by Chris Reese)

((; 1-202-898-8398; Reuters Messaging:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.